Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
TerrAscend Corp provides update on sales licence application
TORONTO, March 9, 2018 /CNW/ – At the request of IIROC and as a result of the recent increase in market activity, TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is providing an update on its sales licence application. Solace Health Inc. (“Solace”), a wholly-owned subsidiary of TerrAscend, has completed the final stages of its application for a sales licence that would permit it to sell dried cannabis from its production facility located in Mississauga, Ontario. Solace has responded to all of Health Canada’s requests to date and is waiting for final approval.
TerrAscend is a Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of consumers. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licenced producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.
Please visit www.TerrAscend.com for more information about the Company.
The most reliable, fact-based information on TerrAscend found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.